Tag:
Eli Lilly
Latest Headlines
Latest Headlines
Pharma reps tone down sales pitch, focus on service
If you think the pharmaceutical reps you see in your office have softened their sales pitches recently, you're not imagining things. According to an article in The Wall Street Journal, it's an
Health advocacy nonprofits rarely disclose drug industry ties
Nonprofits that influence health policy are getting money in the form of grants from the pharmaceutical industry, according to a study published in the American Journal of Public Health. But they're
Medical educators in Pennsylvania received at least $10 million from drug companies in 2009
Conflict-of-interest allegations aside, several Pittsburgh-area doctors and nurse educators are insisting that their work is not compromised despite data showing they were paid roughly $3.5 million
Lilly exec will explore links to industry at Harvard
An executive with Eli Lilly has accepted a job with Harvard Medical School that will entail studying the relationship between the school's researchers and the pharmaceutical industry. William Chin,
Generic drugmakers protest paying in for health reform
Looked at it one way, generic drug manufacturers are getting quite a break when it comes to financing health reform. Under the Senate Finance Committee bill approved last week, the hospital industry
CVS Caremark attacked for allegedly deceptive drug ads
In what was supposed to be a bit of routine business, CVS Caremark recently sent out a series of promotional mailings to doctors on behalf of a handful of major drugmakers, including Eli Lilly,
IOM slams practice of accepting pharma swag
Over the last 18 months or so, the political climate has gotten pretty darned unfriendly for doctors who chose to accept pharma money or gifts. In some cases their parent organizations have banned
Government plans investigation of devicemaker kickbacks to surgeons
Federal health officials and prosecutors are mounting an investigation designed to identify doctors how accept kickbacks from drug and devicemakers for using their products. The investigation focuses
Pfizer will disclose payments to health professionals
Pfizer has announced that it plans to make data on payments to healthcare professionals publicly available starting in early 2010, including not only physicians, but also researchers and research
Lilly to pay $1.4B to settle Zyprexa marketing charges
For some time now, advocates for seniors have complained that anti-psychotic drugs were being used to chemically restrain demented patients, leaving them sedated and unaware. Now one drugmaker, Eli
